http://www.unboundmedicine.com/medline/ebm/research/zafirlukastUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19011932/full_citation/Zafirlukast_Pocket_Delivery_Impairs_the_Capsule_Healing_Around_Textured_Implants_in_Rats_Moreira M, Fagundes DJ, de Jesus Simões M, et al. 
Zafirlukast Pocket Delivery Impairs the Capsule Healing Around Textured Implants in Rats. [JOURNAL ARTICLE]
Aesthetic Plast Surg 2008 Nov 15.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18704935/full_citation/Evidence_for_a_pathophysiological_role_of_cysteinyl_leukotrienes_in_classical_Hodgkin_lymphoma_Schain F, Tryselius Y, Sjöberg J, et al. 
Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma. [JOURNAL ARTICLE]
Int J Cancer 2008 Aug 14.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18651869/full_citation/Cysteinyl_leucotriene_receptor_type_1_mediates_contraction_in_human_and_guinea_pig_oesophagus_Chang BS, Chang JC, Wang YS, et al. 
Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus. [JOURNAL ARTICLE]
Neurogastroenterol Motil 2008 Jul 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18489783/full_citation/Tolerance_and_rebound_with_zafirlukast_in_patients_with_persistent_asthma_Reid DW, Misso NL, Aggarwal S, et al. 
Tolerance and rebound with zafirlukast in patients with persistent asthma. [JOURNAL ARTICLE]
J Negat Results Biomed 2008 May 19; 7(1):3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18420007/full_citation/[Impact_of_new_therapeutic_products_for_the_treatment_of_chronic_obstructive_pulmonary_disease_and_asthma_in_primary_care_in_Madrid_between_1996_and_2005_]Rodríguez Escolar C, Fidalgo García ML 
[Impact of new therapeutic products for the treatment of chronic obstructive pulmonary disease and asthma in primary care in Madrid between 1996 and 2005.] [English Abstract, Journal Article]
Gac Sanit 2008 Mar-Apr; 22(2):105-14.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18367842/full_citation/Reduction_of_Capsular_Thickness_around_Silicone_Breast_Implants_by_Zafirlukast_in_Rats_Spano A, Palmieri B, Palmizi Taidelli T, et al. 
Reduction of Capsular Thickness around Silicone Breast Implants by Zafirlukast in Rats. [JOURNAL ARTICLE]
Eur Surg Res 2008 Mar 27; 41(1):8-14.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18309904/full_citation/Pharmacological_intervention_to_the_inflammatory_response_from_decompression_sickness_in_rats_Little T, Butler BD 
Pharmacological intervention to the inflammatory response from decompression sickness in rats. [Journal Article, Research Support, U.S. Gov't, Non-P.H.S.]
Aviat Space Environ Med 2008 Feb; 79(2):87-93.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18254142/full_citation/Development_and_validation_of_a_sensitive_LC_MS/MS_method_with_electrospray_ionization_for_quantitation_of_zafirlukast_a_selective_leukotriene_antagonist_in_human_plasma:_application_to_a_clinical_pharmacokinetic_study_Bharathi DV, Naidu A, Jagadeesh B, et al. 
Development and validation of a sensitive LC-MS/MS method with electrospray ionization for quantitation of zafirlukast, a selective leukotriene antagonist in human plasma: application to a clinical pharmacokinetic study. [JOURNAL ARTICLE]
Biomed Chromatogr 2008 Feb 6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18095656/full_citation/Metabolic_Activation_of_a_Novel_3_Substituted_Indole_Containing_TNF_alpha_Inhibitor:_Dehydrogenation_and_Inactivation_of_CYP3A4_Sun H, Yost GS 
Metabolic Activation of a Novel 3-Substituted Indole-Containing TNF-alpha Inhibitor: Dehydrogenation and Inactivation of CYP3A4. [JOURNAL ARTICLE]
Chem Res Toxicol 2007 Dec 21.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18072343/full_citation/[Adverse_effects_with_the_leukotriene_antagonist]Chohnabayashi N, Sugiura R, Nishimura N 
[Adverse effects with the leukotriene-antagonist] [Journal Article]
Nippon Rinsho 2007 Oct 28.:272-6.
Full Citation | Find Related Articles